{"id":"https://openalex.org/W1966173192","doi":"https://doi.org/10.1017/s1461145709991222","title":"F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity","display_name":"F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-11","ids":{"openalex":"https://openalex.org/W1966173192","doi":"https://doi.org/10.1017/s1461145709991222","mag":"1966173192","pmid":"https://pubmed.ncbi.nlm.nih.gov/20059805"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145709991222","doi":"https://doi.org/10.1017/s1461145709991222","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145709991222","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/10/1285/1864755/13-10-1285.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966173192"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ijnp/article-pdf/13/10/1285/1864755/13-10-1285.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111812553","display_name":"Marie\u2010Bernadette Assi\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie-Bernadette Assi\u00e9","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080830822","display_name":"Laurent Bardin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laurent Bardin","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062308579","display_name":"Agn\u00e8s L. Auclair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Agn\u00e8s L. Auclair","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110055161","display_name":"Elisabeth Carilla-Durand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisabeth Carilla-Durand","raw_affiliation_strings":["ADME/Tox Department, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ADME/Tox Department, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000797879","display_name":"Ronan Depoort\u00e8re","orcid":"https://orcid.org/0000-0003-0970-420X","observed_orcids":["https://orcid.org/0000-0003-0970-420X"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronan Depoort\u00e8re","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080164174","display_name":"Wouter Koek","orcid":"https://orcid.org/0000-0002-9049-9719","observed_orcids":["https://orcid.org/0000-0002-9049-9719"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wouter Koek","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083060102","display_name":"Mark S. Kleven","orcid":"https://orcid.org/0000-0001-5413-4475","observed_orcids":["https://orcid.org/0000-0001-5413-4475"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark S. Kleven","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109195052","display_name":"Fran\u00e7is C. Colpaert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francis Colpaert","raw_affiliation_strings":["Research Management, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Management, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046760267","display_name":"Bernard Vacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard Vacher","raw_affiliation_strings":["Medicinal Chemistry I Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry I Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045801598","display_name":"Adrian Newman\u2010Tancredi","orcid":"https://orcid.org/0000-0002-2923-5714","observed_orcids":["https://orcid.org/0000-0002-2923-5714"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Adrian Newman-Tancredi","raw_affiliation_strings":["Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology II Division, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":["https://openalex.org/I4210143394"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045801598"],"corresponding_institution_ids":["https://openalex.org/I4210143394"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":4.7068,"has_fulltext":true,"cited_by_count":119,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94526546,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"13","issue":"10","first_page":"1285","last_page":"1298"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7020999789237976,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7020999789237976,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.28760001063346863,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.8199999928474426},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.7120000123977661},{"id":"https://openalex.org/keywords/hypothermia","display_name":"hypothermia","score":0.7919999957084656},{"id":"https://openalex.org/keywords/plasma-corticosterone","display_name":"plasma corticosterone","score":0.9210000038146973},{"id":"https://openalex.org/keywords/body-temperature","display_name":"body temperature","score":0.640999972820282},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.6800000071525574},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.46399998664855957},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.8909516930580139},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7123572826385498},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.6244449615478516},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6197029948234558},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.6062776446342468},{"id":"https://openalex.org/C2780352252","wikidata":"https://www.wikidata.org/wiki/Q422543","display_name":"Corticosterone","level":3,"score":0.5939503908157349},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5850242972373962},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5400015711784363},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.5381115078926086},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5285061001777649},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48379868268966675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47544431686401367},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.440790593624115},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.368692010641098},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3677593171596527},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.35537564754486084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25806331634521484},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.24762141704559326},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22699442505836487},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003345","descriptor_name":"Corticosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003345","descriptor_name":"Corticosterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007035","descriptor_name":"Hypothermia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013312","descriptor_name":"Stress, Physiological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013550","descriptor_name":"Swimming","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017397","descriptor_name":"Prefrontal Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D023421","descriptor_name":"Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058825","descriptor_name":"Serotonin 5-HT1 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1461145709991222","doi":"https://doi.org/10.1017/s1461145709991222","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145709991222","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/10/1285/1864755/13-10-1285.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:20059805","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20059805","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1017/s1461145709991222","doi":"https://doi.org/10.1017/s1461145709991222","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145709991222","pdf_url":"https://academic.oup.com/ijnp/article-pdf/13/10/1285/1864755/13-10-1285.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1966173192.pdf","grobid_xml":"https://content.openalex.org/works/W1966173192.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W10383471","https://openalex.org/W107475310","https://openalex.org/W1585339076","https://openalex.org/W1928975456","https://openalex.org/W1967319780","https://openalex.org/W1968912840","https://openalex.org/W1973846707","https://openalex.org/W1986511266","https://openalex.org/W1990167177","https://openalex.org/W1997541372","https://openalex.org/W2006460397","https://openalex.org/W2012250334","https://openalex.org/W2018004511","https://openalex.org/W2019921154","https://openalex.org/W2022468859","https://openalex.org/W2026736418","https://openalex.org/W2028524283","https://openalex.org/W2030005394","https://openalex.org/W2031881778","https://openalex.org/W2033017106","https://openalex.org/W2036760553","https://openalex.org/W2050423574","https://openalex.org/W2055712541","https://openalex.org/W2056431067","https://openalex.org/W2057532104","https://openalex.org/W2065448957","https://openalex.org/W2065664987","https://openalex.org/W2071963193","https://openalex.org/W2072182596","https://openalex.org/W2076547272","https://openalex.org/W2081458788","https://openalex.org/W2083549526","https://openalex.org/W2086393860","https://openalex.org/W2091648211","https://openalex.org/W2096227949","https://openalex.org/W2097241494","https://openalex.org/W2098761489","https://openalex.org/W2113765770","https://openalex.org/W2122321697","https://openalex.org/W2130423340","https://openalex.org/W2131236523","https://openalex.org/W2159748063","https://openalex.org/W2169615651","https://openalex.org/W2169891500","https://openalex.org/W2219106550","https://openalex.org/W2304131176","https://openalex.org/W2312088836","https://openalex.org/W2327088997","https://openalex.org/W4214712052","https://openalex.org/W4233178025","https://openalex.org/W4414041363"],"related_works":["https://openalex.org/W1967319780","https://openalex.org/W2006460397","https://openalex.org/W1588173517","https://openalex.org/W2781010046","https://openalex.org/W3161692348","https://openalex.org/W1984815383","https://openalex.org/W2024312854","https://openalex.org/W2065060087","https://openalex.org/W2519908040","https://openalex.org/W3113553641"],"abstract_inverted_index":{"F15599":[0,22,50,88,108,131,166,175,204,221],"is":[1,181],"a":[2,32,57,155,206,230],"novel":[3],"agonist":[4],"with":[5,54],"high":[6],"selectivity":[7],"and":[8,19,67,82,104,146,162],"efficacy":[9],"at":[10,96,123],"serotonin":[11],"5-HT(1A)":[12],"receptors":[13],"(5-HT(1A)Rs).":[14],"In":[15,126,202],"signal":[16],"transduction,":[17],"electrophysiological":[18],"neurochemical":[20],"tests,":[21],"preferentially":[23],"activates":[24],"post-synaptic":[25,227],"5-HT(1A)Rs":[26,228],"in":[27,61,93,176],"rat":[28,62],"frontal":[29],"cortex.":[30],"Such":[31],"profile":[33,39,219],"may":[34],"translate":[35],"to":[36,134,147,183,211],"an":[37,194],"improved":[38,234],"of":[40,49,56,64,87,107,130,140,158,174,178,185,199,220,226],"therapeutic":[41],"activity":[42,66,180],"for":[43,165,168,233],"mood":[44],"disorders.":[45],"The":[46,216],"in-vivo":[47,172],"effects":[48,100,106,164],"were":[51,101,109,132],"therefore":[52],"compared":[53],"those":[55],"related":[58],"compound,":[59],"F13714,":[60,186],"models":[63,177],"antidepressant":[65,235],"5-HT(1A)R":[68],"activation:":[69],"forced":[70],"swimming":[71],"test":[72],"(FST),":[73],"conditioned":[74],"stress-induced":[75],"ultrasonic":[76,120],"vocalization,":[77],"5-HT":[78,142],"syndrome,":[79,144],"plasma":[80,149],"corticosterone":[81,150],"body":[83],"temperature.":[84],"Acute":[85],"administration":[86],"or":[89],"F13714":[90,210],"reduced":[91],"immobility":[92],"the":[94,105,141,171,188,191],"FST":[95,161],"low":[97,124],"doses;":[98],"these":[99],"long":[102],"lasting":[103],"maintained":[110],"after":[111],"repeated":[112],"(5":[113],"d,":[114],"p.o.)":[115],"administration.":[116],"Both":[117],"compounds":[118],"decreased":[119],"vocalization":[121],"duration":[122],"doses.":[125],"contrast,":[127],"higher":[128],"doses":[129],"required":[133],"induce":[135,212],"lower":[136,207],"lip":[137],"retraction,":[138],"elements":[139],"behavioural":[143],"hypothermia":[145],"increase":[148],"levels.":[151],"Notably,":[152],"there":[153],"was":[154],"greater":[156],"separation":[157],"ED50":[159],"between":[160],"other":[163,213],"than":[167,209],"F13714.":[169],"Thus,":[170],"potency":[173,196],"antidepressant/anti-stress":[179],"similar":[182],"that":[184,190,223],"despite":[187],"fact":[189],"latter":[192],"has":[193,205],"in-vitro":[195],"two":[197],"orders":[198],"magnitude":[200],"greater.":[201],"contrast":[203],"propensity":[208],"serotonergic":[214],"signs.":[215],"distinctive":[217],"pharmacological":[218],"suggests":[222],"preferential":[224],"targeting":[225],"constitutes":[229],"promising":[231],"strategy":[232],"therapy.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966173192","counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
